1. F. Poccia, M. L. Gougeon, M. Bonneville, M. Lòpez-Botet, A. Moretta, L. Battistini, M. Wallace, V. Colizzi, and M. Malkovsky. Innate T-cell immunity to
nonpeptidic antigens. Immunol. Today (1998); 19: 253-256

2. M. Piacentini & V. Colizzi Tissue transglutaminase: apoptosis versus autoimmunity. Immunol. Today , (1999); 20:130-133

3. Kornfeld H., Mancino G., and Colizzi V. The role of macrophage cell death in Tuberculosis. Cell Death Differ, (1999); 6: 71-78.

4. M. L. Gougeoun, S. Boulier, V. Colizzi and F. Poccia. NKR-mediated control of gd T cell immunity to viruses. Microbes and Infection, (1999);1 219-226

5. Bergamini A., Faggioli E., Bolacchi F., Gessani S., Cappannoli L., Uccella I., Demin F., Capozzi M., Cicconi R., Placido R., Vendetti S., Mancino G., Colizzi V.,
Rocchi G. Enhanced production of TNF-a and Il-6, due to prolonged cytokine response to LPS stimulation, in cultured human macrophages infected in vitro with
HIV-1. J. Infect. Dis, (1999); 179, 832-42

6. F. Poccia, L. Battistini, B. Cipriani, G. Mancino, F. Martini, M. L. Gougeon and V. Colizzi. Phosphoantigen-reactive Vg9Vd2 T Lymphocytes Suppress in vitro
Human Immunodeficiency Virus Type 1 Replication by Cell and Antiviral Factors Including CC-Chemochines J. Inf. Dis. (1999); 180:858-61

7. F. Poccia, M. Malkovsky, A. Pollak, V. Colizzi, G. Sireci, A. Salerno and F. Dieli. In vivo gd T cell priming to mycobacterial antigens by primary M.tuberculosis
infection and exposure to nonpeptidic ligands. Molecular Medicine (1999); 5: 471-476

8. M. Fraziano, G. Cappelli, M. Santucci, F. Mariani, M. Amicosante, M. Casarini, S. Giosuè, A Bisetti and V. Colizzi. Expression of CCR5 Is Increased in Human
Monocyte-Derived Macrophages in the Course of in Vivo and in Vitro Mycobacterium tuberculosis Infection. AIDS Res. Hum. Retrov.(1999); 15, 869-874

9. G. Antonelli, E. Riva, F. Maggi, M. L.Vatteroni and E. Simeoni. Influence of Hepatitis C Virus (HCV) Genotype, HCV RNA Load, and Alanine Aminotransferase
Level on Reduction of HCV RNA after a Single Administration of Interferon a. J.Inf Dis (1999); 180, 1411-12

10. S. Uccini, E. Riva, G. Antonelli, G. D’Offizi, A. Prozzo, A. Angelici, A. Faggioni, A. Angeloni, M. R. Torrisi, M. Gentile, C. D. Baroni and L. P. Ruco. The Benign
Cystic Lymphoepithelial Lesion of the Parotid Glands Is a Viral Reservoir in HIV Type 1-Infected Patients. AIDS Res. Hum. Retrov. (1999); 15, 1339-1344

11. Antonelli and F. Dianzani. Development of antibodies to interferon beta in patients: technical and biological aspects. Eur.Cytokine Netw. (1999); 10, 413-422

12. G. Antonelli, E. Simeoni, F. Bagnato, C. Pozzilli, O. Turriziani, R. Tesoro, P. Di Marco, C. Gasperini, C. Fieschi, F. Dianzani. Further study on the specificity and
incidence of neutralising antibodies to interferon (TNF) in relapsing remitting multiple sclerosis patients treated whit IFN beta -1a or IFN beta –1b. J.Neurol Sci.
(1999); 168, 131-6

13. G. Borsellino, F. Poccia, R. Placido, D. Tramonti, G. Mancino, S. Lucchetti, S. Galgani, B. Bonetti, S. Bach, B. Cipriani, C. F. Brosnan and L. Battistini.
Phenotypic and functional properties of gd T Cells from patients with Guillain Barré syndrome. J.Neuroimmunol.(2000); 102, 199-207

14. B. Cipriani, G. Borsellino, F. Poccia, R. Placido, D. Tramonti, S. Bach, L. Battistini and C. F. Brosnan. Activation of C-C bchemokines in human paripheral blood
gd T cells by isopentenyl pyrophoshate and regulation by cytochines. Blood. (2000); 95, 39-47

15. Gougeon ML, Boullier S, Colizzi V, Poccia F. NKR-mediated control of gammadelta T-cell immunity to viruses. Microbes Infect. 1999 Mar;1(3):219-26.

16. Gougeon ML, Poccia F, Boullier S. Human gamma delta T lymphocytes in HIV disease: effector functions and control by natural killer cell receptors. Springer Semin Immunopathol. 2000;22(3):251-63.

17. Malkovsky M, Wallace M, Fournie JJ, Fisch P, Poccia F, Gougeon ML. Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gammadelta T lymphocytes and natural killer cells AIDS. 2000;14 Suppl 3:S175-86.

18 Martini F, Urso R, Gioia C, De Felici A, Narciso P, Amendola A, Paglia MG, Colizzi V, Poccia F. Gamma/daelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy. Immunology. 2000 Aug;100(4):481-6.

19. Amendola A, Poccia F, Martini F, Gioia C, Galati V, Pierdominici M, Marziali M, Pandolfi F, Colizzi V, Piacentini M, Girardi E, D'offizi G. Decreased CD95 expression on naive T cells from HIV-infected persons undergoing highly active anti-retroviral therapy (HAART) and the influence of IL-2 low dose administration. Irhan Study Group. Clin Exp Immunol. 2000 May;120(2):324-32.

20. Turriziani O, Di Marco P, Antonelli G, Dianzani F. May the drug transporter P glycoprotein affect the antiviral activity of human immunodeficiency virus type 1 proteinase inhibitors?
Antimicrob Agents Chemother. 2000 Feb;44(2):473-4.

21. Persichini T., Ascenzi P., Colizzi V., Fraziano M., Venturini G., Colasanti M. Molecular bases for the anti-HIV-1 effect of NO. Int J Mol Med (1999) 4: 365-368

22. Persichini T., Colasanti M., Fraziano M., Colizzi V., Ascenzi P., Lauro G.M. Nitric oxide inhibits HIV-1 replication in human astrocytoma cells. Biochem Biophys Res Commun (1999) 254: 200-202

23. Santucci M., Amicosante M., Cicconi R., Montesano C., Casarini M., Giosuè S., Bisetti A., Colizzi V., Fraziano M. Mycobacterium tuberculosis induced apoptosis in monocytes/macrophages: early membrane modifications and intracellular mycobacterial survival. J. Infect. Dis. 2000; 181: 1506-9

24. Colasanti M., Persichini T. Nitric oxide: an inhibitor of NF-kappaB/Rel system in glial cells. Brain Res Bull . (2000) 52: 155-61.

25. Ciaramella A., Martino A., Cicconi R., Colizzi V., Fraziano M. Mycobacterial 19 kDA lipoprotein mediates Mycobacterium tuberculosis H37Rv-induced apoptosis in monocytes/macrophages at early stages of infection. Cell Death and Differ., (in press)

26. Mariani F., Goletti D., Ciaramella A., Martino A., Colizzi V., Fraziano M. Macrophage response to Mycobacterium tuberculosis: relationships between activation and apoptosis. Curr. Mol. Med. (1n press)